10,9 %Ten point nine percent of women had infections with multiple HPV strains.
Nigeriainfection à HPVpublié 2026Diagnostic microbiology and infectious diseasePubMeddocument de 21 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
148 evidences · page 6 / 6
10,9 %Ten point nine percent of women had infections with multiple HPV strains.
Nigeriainfection à HPVpublié 2026Diagnostic microbiology and infectious diseasePubMeddocument de 21 observations
79,1 %79.1% (34/43) of art entries aimed to promote human papillomavirus screening and vaccination.
Nigeriainfection à HPVpublié 2026JMIR formative researchPubMeddocument de 7 observations
54 %Nigeria's HPV vaccination coverage is currently estimated at 54%.
Nigeriainfection à HPVPubMeddocument de 4 observations
10,6 %Only 10.6% of female secondary school students had been vaccinated against HPV.
Nigeriainfection à HPVPubMeddocument de 7 observations
16,6 %The prevalence of oral human papillomavirus (oHPV) among 584 men who have sex with men in Abuja and Lagos, Nigeria, was 16.6%.
Nigeriainfection à HPVobservé 2014 to 2018publié 2026International journal of STD & AIDSPubMeddocument de 4 observations
18,5 %18.5% of the respondents reported that their children had been vaccinated against HPV.
Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations
56,6 %56.6% of the respondents reported that they will advise their friends to be vaccinated against HPV.
Nigeriainfection à HPVpublié 2023African journal of reproductive healthPubMeddocument de 5 observations
42,3 %42.3% of rural women in North Central Nigeria recognized HPV infection as a risk factor for cervical cancer.
Nigeriacancer du col de l'utérus · infection à HPVpublié 2026Rural and remote healthPubMeddocument de 21 observations
20,65 %The pooled prevalence of cervical HPV in Nigerian women was 20.65%.
Nigeriainfection à HPVpublié 2021Annals of medicinePubMeddocument de 9 observations
1 %HPV vaccine actual uptake remained low at 1% to 15% in most studies conducted in Nigeria.
Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 3 observations
11,3 %In the study, 11.3% of refusals for the HPV vaccine were due to lack of adequate information among students in four secondary schools in Benin City, Nigeria.
Nigeriainfection à HPVpublié 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 10 observations
3 casesThree mothers living with HIV had their daughters vaccinated against HPV.
Nigeriainfection à HPVpublié 2026BMC public healthPubMeddocument de 8 observations
53,7 %Among urban participants in Ibadan, Nigeria, 53.7% preferred HPV self-sampling.
Nigeriainfection à HPVpublié 2026BMJ openPubMeddocument de 11 observations
56,6 %Among peri-urban participants in Ibadan, Nigeria, 56.6% preferred healthcare provider (HCP) sample collection for HPV testing.
Nigeriainfection à HPVpublié 2026BMJ openPubMeddocument de 11 observations
23 %Among 342 men who have sex with men (MSM) in Nigeria, HPV16 prevalence was 23%.
Nigeriainfection à HPVpublié 2020Papillomavirus research (Amsterdam, Netherlands)PubMeddocument de 19 observations
1,4 %HPV awareness among adolescents increased from 1.4% to 19.0% following sensitization.
Nigeriainfection à HPVpublié 2026Journal of the International AIDS SocietyPubMeddocument de 5 observations
2,1 aORLiving with HIV for over 6 years was independently associated with a two-fold increased knowledge about HPV's carcinogenicity (adjusted odds ratio: 2.1, 95% confidence interval: 1.1–4.1).
Nigeriainfection à HPV · VIH/sidapublié 2025Sexual healthPubMeddocument de 9 observations
5 %Human Papillomavirus is responsible for about 5% of the global cancer burden.
Nigeriainfection à HPVpublié 2024Reproductive healthPubMeddocument de 16 observations
HPV was not identified in HIV-positive patients with oropharyngeal carcinomas.
Nigeriainfection à HPV · oropharyngeal carcinomas · VIH/sidapublié 2021The Pan African medical journalPubMeddocument de 4 observations
0,11 aORThe odds of oral HPV and EBV co-infection was lower among males [aOR = 0.11, 95% CI: 0.00–14.51].
Nigeriainfection à HPV · virus Epstein-Barrpublié 2025BMC oral healthPubMeddocument de 4 observations
35,2 %Willingness to receive the HPV vaccine among female secondary school students increased from 35.2% to 79.8% after the intervention.
Nigeriainfection à HPVPubMeddocument de 7 observations
1,9 aORAmong participants in the TRUST/RV368 cohort, recent receptive sex was associated with highly similar anal HPV genotypes at 3 months (adjusted odds ratio 1.9, 95% CI 1.0–3.5).
Nigeriainfection à HPVpublié 2022Sexually transmitted diseasesPubMeddocument de 13 observations
28,1 %28.1% of the participants recognized vaccination as a preventive strategy against HPV infection.
Nigeriainfection à HPVpublié 2024BMC public healthPubMeddocument de 12 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.